NCI and Cancer Research UK awarded $125 million in total funding through the Cancer Grand Challenges program, supporting research on cancer inequities, early-onset cancers, solid tumors in children, and T-cell receptors. The $125 million investment marks the Cancer Grand Challenges program’s largest funding round to date.
Cancer Research UK set out how the next U.K. Government could reduce cancer mortality rates by preventing thousands of future cancers as well as dramatically improving cancer survival.
Cancer Research UK and the KWF Dutch Cancer Society, have entered a multi-project strategic partnership to advance promising therapeutic agents for cancer through early clinical development.
Cancer Research UK and France’s Institut National du Cancer have partnered to fund researchers through the global Cancer Grand Challenges initiative.
NCI and Cancer Research UK announced nine new research challenges aimed at tackling some of the most profound problems in cancer research. The global funding opportunity is part of the Cancer Grand Challenges program, an initiative launched by NCI and Cancer Research UK in 2020.
Cancer Research UK, The University of Manchester, and Roche Products Ltd. opened a multi-drug, precision medicine trial for people with rare cancers who need more treatment options. The trial is set up to recruit both pediatric and adult patients with any rare cancer type.
Catherine Bollard and her team have an ambitious goal: To establish CAR T-cell therapies as the standard of care for pediatric solid tumors within the next 10 years. CAR Ts have made little to no clinical traction in solid tumors thus far, despite their success in some blood cancers.
Cancer Grand Challenges, a funding initiative co-founded by Cancer Research UK and NCI, brings together a community of diverse, world-class researchers to tackle cancer’s toughest challenges. Researchers, patient advocates, and the public are invited to submit ideas to shape its next round of funding and to help drive vital progress against cancer.
NCI and Cancer Research UK have awarded $100 million in total funding through the Cancer Grand Challenges program, supporting research into solid tumors in children, cachexia, extrachromosomal DNA, and tumor development.